Pierini S, Tanyi J, Simpkins F, George E, Uribe Herranz M, Drapkin R, et al. Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight. 2020;5: pubmed publisher

Pribyl M, Hubackova S, Moudra A, Vancurova M, Polackova H, Stopka T, et al. Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes. Mol Oncol. 2020;14:2403-2419 pubmed publisher

Nguyen M, Hosokawa K, Yoroidaka T, Maruyama H, Espinoza J, Elbadry M, et al. Resistance of KIR Ligand-Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia. Immunohorizons. 2020;4:430-441 pubmed publisher

Zhang J, Lu Y, Wang W, Liu G, Chen C, Shen L, et al. BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3+ Treg Polarization. Front Immunol. 2020;11:518 pubmed publisher

Furie R, Werth V, Merola J, Stevenson L, Reynolds T, Naik H, et al. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. J Clin Invest. 2019;129:1359-1371 pubmed publisher

Han S, Kim S, Kim H, Lee Y, Choi S, Park G, et al. Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia. Leukemia. 2017;31:1532-1539 pubmed publisher

Serr I, Fürst R, Achenbach P, Scherm M, Gökmen F, Haupt F, et al. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. Nat Commun. 2016;7:10991 pubmed publisher